Showing results (2571-2580 of 3,836) with videos related to
Sort By:
Pageof 384
Cancer Cell|June 25, 2021
The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistanceSunil K Joshi, Tamilla Nechiporuk, Daniel Bottomly, et al.Cancer Cell|March 19, 2020
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic CancerSamarth Hegde, Varintra E Krisnawan, Brett H Herzog, et al.Cancer Cell|March 19, 2020
Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived NanocellsSharon M Sagnella, Lu Yang, Gemma E Stubbs, et al.Cancer Cell|March 19, 2020
Genomic and Transcriptomic Characterization of Natural Killer T Cell LymphomaJie Xiong, Bo-Wen Cui, Nan Wang, et al.Cancer Cell|February 1, 2020
THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T CellsChuang Sun, Peishun Shou, Hongwei Du, et al.Cancer Cell|February 1, 2020
EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP InhibitionSergey Karakashev, Takeshi Fukumoto, Bo Zhao, et al.Cancer Cell|January 25, 2020
Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant CancersDhivya R Sudhan, Angel Guerrero-Zotano, Helen Won, et al.Cancer Cell|January 28, 2020
Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic CancerEric C Cheung, Gina M DeNicola, Colin Nixon, et al.Cancer Cell|September 18, 2020
Cancer Screening, Surrogates of Survival, and the SomaJames DeGregori, Paul Pharoah, Peter Sasieni, et al.Cancer Cell|September 15, 2020
Same Script, Different Cast: Different Cell Origins Shape Molecular Features and Therapeutic Response in GlioblastomaSihan Wu, Paul S MischelPageof 384